Brandriss M W, Betts R F, Mathur U, Douglas R G
Am Rev Respir Dis. 1981 Dec;124(6):681-4. doi: 10.1164/arrd.1981.124.6.681.
Antibody responses to vaccination with monovalent A/USSR/77 (H1N1) and trivalent A/USSR/77 (H1N1)-A/Texas/77 (H3N2)-B/Hong Kong/72 vaccines were examined in a group of elderly persons most of whom had received more than 1 influenza vaccination in the previous 5 yr. Seventy-two per cent had a fourfold or greater increase in hemagglutination inhibition (HA1) titer to A/USSR and 92% had postvaccine titers equal to or greater than 1:40. There were no differences in antibody responses to A/USSR between recipients of monovalent and trivalent vaccines. No booster effect of a second injection of A/USSR was observed in subjects who had failed to respond to the first injection. Although there was a significant correlation between postvaccine HAI titers to A/USSR and to A/Texas, the responses to A/Texas and B/Hong Kong were modest or minimal compared with those to A/USSR. This serologic data may be relevant to the results of surveillance studies that suggest a limited advantage of repeated vaccinations with H3N2 subtypes and should help in evaluating the results of this practice.
在一组老年人中检测了对单价A/苏联/77(H1N1)疫苗和三价A/苏联/77(H1N1)-A/得克萨斯/77(H3N2)-B/香港/72疫苗接种的抗体反应,其中大多数人在过去5年中接受过不止一次流感疫苗接种。72%的人对A/苏联的血凝抑制(HA1)效价有四倍或更高的增长,92%的人接种疫苗后的效价等于或大于1:40。单价疫苗和三价疫苗的接种者对A/苏联的抗体反应没有差异。在对首次注射无反应的受试者中,未观察到第二次注射A/苏联的加强效果。尽管接种疫苗后对A/苏联和对A/得克萨斯的血凝抑制效价之间存在显著相关性,但与对A/苏联的反应相比,对A/得克萨斯和B/香港的反应适度或最小。该血清学数据可能与监测研究结果相关,监测研究表明重复接种H3N2亚型疫苗的优势有限,并且有助于评估这种做法的结果。